miR-190, CDK1, MCM10 and NDC80 predict the prognosis of the patients with lung cancer

1. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 2015;75(S1):191-202. DOI: 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-YOpen DOISearch in Google Scholar

2. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56-63.Search in Google Scholar

3. Mcguire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr. 2016;7(2):418. DOI: 10.3945/an.116.01221110.3945/.116.012211Open DOISearch in Google Scholar

4. Tan X, Fang Z, Wan J, Jie H, Chen Z, Li B et al. Pin1 expression contributes to lung cancer prognosis and carcinogenesis. Cancer Biol Ther. 2010;9(2):111-9. DOI: 10.4161/cbt.9.2.1034110.4161/cbt.9.2.10341Open DOISearch in Google Scholar

5. Yoon HE, Kim SA, Choi HS, Ahn MY, Yoon JH, Ahn SG. Inhibition of Plk1 and Pin1 by 5′-nitro-indirubinoxime suppresses human lung cancer cells. Cancer Lett. 2012;316(1):97-104. DOI: 10.1016/j.canlet.2011.10.02910.1016/j.canlet.2011.10.029Open DOISearch in Google Scholar

6. Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, Cui QZ et al. CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis. Ann Surg Oncol. 2011;18(3):857. DOI: 10.1245/s10434-010-1313-810.1245/s10434-010-1313-8Open DOISearch in Google Scholar

7. Xu P, Xu XL, Huang Q, Zhang ZH, Zhang YB. CIP2A with survivin protein expressions in human non-small. Med Oncol. 2012;29(3):1643-7. DOI: 10.1007/s12032-011-0053-310.1007/s12032-011-0053-3Open DOISearch in Google Scholar

8. Ni S, Xu L, Huang J, Feng J, Zhu H, Wang G et al. Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013;6(12):2887-95.Search in Google Scholar

9. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64(6):399. DOI: 10.1016/j.biopha.2010.01.01810.1016/j.biopha.2010.01.018Open DOISearch in Google Scholar

10. Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagymignotte H et al. Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers. Sci Transl Med. 2013;5(186):186ra66. DOI: 10.1126/scitranslmed.300572310.1126/scitranslmed.3005723Search in Google Scholar

11. Irizarry RA, Wu Z, Jaffee HA. Comparison of Affymetrix GeneChip expression measures. Bioinformatics. 2006;22(7):789. DOI: 10.1093/bioinformatics/btk04610.1093/bioinformatics/btk046Open DOISearch in Google Scholar

12. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7). DOI: 10.1093/nar/gkv00710.1093/nar/gkv007Open DOISearch in Google Scholar

13. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44. DOI: 10.1038/nprot.2008.21110.1038/nprot.2008.21119131956Open DOISearch in Google Scholar

14. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2015;44(D1):D457-D62. DOI: 10.1093/nar/gkv107010.1093/nar/gkv1070470279226476454Open DOISearch in Google Scholar

15. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-31. DOI: 10.1038/nrg137910.1038/nrg137915211354Open DOISearch in Google Scholar

16. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41(W1):77-83. DOI: 10.1093/nar/gkt43910.1093/nar/gkt439369210923703215Open DOISearch in Google Scholar

17. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A et al. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(D1):D808-D15. DOI: 10.1093/nar/gks109410.1093/nar/gks1094353110323203871Open DOISearch in Google Scholar

18. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S et al. A travel guide to Cytoscape plugins. Nat Methods. 2012;9(11):1069-76. DOI: 10.1038/nmeth.221210.1038/nmeth.2212364984623132118Open DOISearch in Google Scholar

19. Morris JH, Apeltsin L, Newman AM, Baumbach J, Wittkop T, Su G et al. clusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC bioinformatics. 2011;12:436 DOI: 10.1186/1471-2105-12-436. DOI: 10.1186/1471-2105-12-43610.1186/1471-2105-12-436.DOI:10.1186/1471-2105-12-436Open DOISearch in Google Scholar

20. Consortium TGO. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):1049-56. DOI: 10.1093/nar/gku117910.1093/nar/gku1179438397325428369Open DOISearch in Google Scholar

21. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005 Aug 15;21(16):3448-9 DOI: 10.1093/bioinformatics/bti551. DOI: 10.1093/bioinformatics/bti55110.1093/bioinformatics/bti551.DOI:10.1093/bioinformatics/bti551Open DOISearch in Google Scholar

22. Kassambara A. survminer: Drawing Survival Curves using ‘ggplot2’. R package version 0.2.2. ed. https://CRAN.R-project.org/package=survminer. 2016.Search in Google Scholar

23. Therneau TM, April. A Package for Survival Analysis in S. version 2.38 ed. http://CRAN.R-project.org/package=survival. 2015.Search in Google Scholar

24. Robinson MD, Mccarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139. DOI: 10.1093/bioinformatics/btp61610.1093/bioinformatics/btp616279681819910308Open DOISearch in Google Scholar

25. Oliveros JC. VENNY. An interactive tool for comparing lists with Venn Diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html. 2007.Search in Google Scholar

26. Jia WZ, Tao Y, Qi A, Hua Y, Zhu Z, Xiao L et al. MicroRNA-190 regulatesFOXP2genes in human gastric cancer. Onco Targets Ther. 2016;9(Issue 1):3643-51.10.2147/OTT.S103682492024327382302Search in Google Scholar

27. Yu Y, Luo W, Yang ZJ, Chi JR, Li YR, Ding Y et al. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Mol Cancer. 2018;17(1):70. DOI: 10.1186/s12943-018-0818-910.1186/s12943-018-0818-9583899429510731Open DOISearch in Google Scholar

28. Liang Z, Kong R, He Z, Lin LY, Qin SS, Chen CY et al. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1. Oncotarget. 2017;8(29):47389-99. DOI: 10.18632/oncotarget.1765010.18632/oncotarget.17650556457328537888Search in Google Scholar

29. Peng Z, Pan L, Niu Z, Li W, Dang X, Lin W et al. Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis. Oncotarget. 2017;8(38):64143. DOI: 10.18632/oncotarget.1935810.18632/oncotarget.19358560999028969058Search in Google Scholar

30. Si L, Tian H, Yue W, Li L, Li S, Gao C et al. Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer. Oncol Lett. 2017;14(4):4325. DOI: 10.3892/ol.2017.666710.3892/ol.2017.6667560416928943946Open DOISearch in Google Scholar

31. Li J, Yu J, Zhang H, Wang B, Guo H, Bai J et al. Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGF beta RII Inhibition. Cell Physiol Biochem. 2016;38(5):1715. DOI: 10.1159/00044311110.1159/00044311127160836Open DOISearch in Google Scholar

32. Shi YX, Zhu T, Zou T, Zhuo W, Chen YX, Huang MS et al. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma. Oncotarget. 2016;7(51):85235. DOI: 10.18632/oncotarget.1325210.18632/oncotarget.13252535673227835911Search in Google Scholar

33. Huang SH, Xiao-Li MA, Qiu C, Huang JA, Kong WH, Xie JW et al. The overexpression of cyclin B1 and CDK1 in lung carcinoma and its clinical significance. Journal of Shandong University. 2004;39(5):122-4.Search in Google Scholar

34. Jacquot C, Rousseau B, Carbonnelle D, Chinou I, Malleter M, Tomasoni C et al. Cucurbitacin-D-induced CDK1 mRNA up-regulation causes proliferation arrest of a non-small cell lung carcinoma cell line (NSCLC-N6). Anticancer Res. 2014;34(9):4797-806.Search in Google Scholar

35. Cooper WA, Kohonencorish MR, Mccaughan B, Kennedy C, Sutherland RL, Lee CS. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Histopathology. 2009;55(1):28-36. DOI: 10.1111/j.1365-2559.2009.03331.x10.1111/j.1365-2559.2009.03331.x19614764Open DOISearch in Google Scholar

36. Takashima S, Saito H, Takahashi N, Imai K, Kudo S, Atari M et al. Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer. Tumour Biol. 2014;35(5):4257-65. DOI: 10.1007/s13277-013-1556-710.1007/s13277-013-1556-724375198Open DOISearch in Google Scholar

37. Liu YZ, Wang BS, Jiang YY, Cao J, Hao JJ, Zhang Y et al. MCMs expression in lung cancer: implication of prognostic significance. J Cancer. 2017;8(18):3641-7. DOI: 10.7150/jca.2077710.7150/jca.20777568891629151950Open DOISearch in Google Scholar

38. Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L et al. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Lung Cancer. 2012;77(1):176. DOI: 10.1016/j.lungcan.2012.03.00110.1016/j.lungcan.2012.03.00122456526Open DOISearch in Google Scholar

39. Kikuchia J, Kinoshitab I, Shimizub Y, Kikuchia E, Takedab K, Abu H. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer. Lung Cancer. 2011;72(2):229-37. DOI: 10.1016/j.lungcan.2010.08.02010.1016/j.lungcan.2010.08.02020884074Open DOISearch in Google Scholar

40. Chao W. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC bioinformatics. 2012;13(1):182. DOI: 10.1186/1471-2105-13-18210.1186/1471-2105-13-182346461522838965Open DOISearch in Google Scholar

41. Hayama S, Daigo Y, Kato T, Ishikawa N, Yamabuki T, Miyamoto M et al. Activation of CDCA1-KNTC2, Members of Centromere Protein Complex, Involved in Pulmonary Carcinogenesis. 2006;66(21):10339-48.10.1158/0008-5472.CAN-06-2137Search in Google Scholar